N/A
Completed N=12
A New Adaptive Physical Activity Technology in Older Adults
Source: ClinicalTrials.gov NCT02467491 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jun 2016
Primary outcomePrimary: Quality of Movements' Total Average Score — 87 percentage of quality of movements
Summary
The purpose of this study is to explore the feasibility and acceptability of a new physical activity technology (Jintronix) based on TV screen, virtual games and motion sensing cameras among pre-disabled older adults.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Movements' Total Average Score |
87 | — |
| PRIMARY Total Average Time in Performing Exercises With Jintronix. |
207.5 | — |
| PRIMARY Global Difficulty Score |
13 | — |
| PRIMARY Global Appreciation Score |
33 | — |
| SECONDARY Change From Baseline to 4 Weeks in the Short Physical Performance Battery Test |
0.67 | 0.04 sig |
| SECONDARY Change From 4 Weeks (End of Intervention) to 3 Months After the End of the Intervention in the Short Physical Performance Battery Test |
0.42 | 0.02 sig |
Eligibility Criteria
Inclusion Criteria
- Age 75 years and older
- Pre-disabled status evidenced by: 6 ≤ score ≤ 9 on the Short Physical Performance Battery test.
- Willingness to participate in all study procedures.
Exclusion Criteria
- Failure to provide informed consent
- Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
- Significant cognitive impairment, defined as a known diagnosis of dementia or a short portable mental status questionnaire score > 2 errors
- Unable to communicate because of severe hearing loss or speech disorder
- Severe visual impairment, which would preclude completion of the assessments and/or exercise program
- Other significant co-morbid diseases that would prevent participation in exercise
- Planning to move out of the area during the study timeframe
Data sourced from ClinicalTrials.gov (NCT02467491). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.